Neuropeptide Y modifies the disease course in the R6/2 transgenic model of Huntington's disease (Q42951048)

11 November 2017

title

Neuropeptide Y modifies the disease course in the R6/2 transgenic model of Huntington's disease (English)

1 reference

11 November 2017

0 references

5

R. A. Barker

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20673761

14 June 2024

M. Decressac

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20673761

14 June 2024

B. Wright

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20673761

14 June 2024

P. Tyers

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20673761

14 June 2024

A. Gaillard

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20673761

14 June 2024

language of work or name

English

0 references

publication date

29 July 2010

1 reference

full work available at URL

11 November 2017

https://api.elsevier.com/content/article/PII:S0014488610002608?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

https://api.elsevier.com/content/article/PII:S0014488610002608?httpAccept=text/plain

14 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

14 June 2024

published in

Experimental Neurology

1 reference

11 November 2017

volume

226

1 reference

11 November 2017

issue

1

1 reference

11 November 2017

page(s)

24-32

1 reference

Neuropeptide Y distribution in human brain

11 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Neuropeptide Y promotes neurogenesis in murine subventricular zone.

14 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Neuropeptide Y Distribution in the Rat Brain

14 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Neuropeptide Y protects retinal neural cells against cell death induced by ecstasy.

14 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid

14 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Somatostatin and neuropeptide Y concentrations in pathologically graded cases of Huntington's disease

14 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies.

14 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation.

14 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Induction of neostriatal neurogenesis slows disease progression in a transgenic murine model of Huntington disease

14 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats

14 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain

14 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

The distribution of progenitor cells in the subependymal layer of the lateral ventricle in the normal and Huntington's disease human brain

14 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

A histochemical and immunohistochemical analysis of the subependymal layer in the normal and Huntington's disease brain

14 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

14 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease

14 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Neuropeptide Y stimulates proliferation, migration and differentiation of neural precursors from the subventricular zone in adult mice

14 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Exogenous neuropeptide Y promotes in vivo hippocampal neurogenesis.

14 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Proliferating neural precursor cells as first step toward neuroregeneration in Huntington's disease?

14 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice

14 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Neuropeptide Y administration into the amygdala suppresses ethanol drinking in alcohol-preferring (P) rats following multiple deprivations.

14 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

The metabolic profile of early Huntington's disease--a combined human and transgenic mouse study

14 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

The efficiency of systematic sampling in stereology and its prediction.

14 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis.

14 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Neuropeptide Y functions as a neuroproliferative factor

14 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Translating therapies for Huntington's disease from genetic animal models to clinical trials

14 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Neuropeptide Y is neuroproliferative for post-natal hippocampal precursor cells

14 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Neuropeptide Y stimulates neuronal precursor proliferation in the post-natal and adult dentate gyrus

14 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Neuropeptide Y is important for basal and seizure-induced precursor cell proliferation in the hippocampus

14 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Huntington's disease: from pathology and genetics to potential therapies

14 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease

14 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

NPY and cohorts in regulating appetite, obesity and metabolic syndrome: beneficial effects of gene therapy.

14 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Decreased hippocampal cell proliferation in R6/1 Huntington's mice.

14 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Olfactory abnormalities in Huntington's disease: decreased plasticity in the primary olfactory cortex of R6/1 transgenic mice and reduced olfactory discrimination in patients

14 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Neuropeptide Y: a potent inducer of consummatory behavior in rats

14 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

14 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Lack of association between PSA-NCAM expression and migration in the rostral migratory stream of a Huntington's disease transgenic mouse model

14 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Neuropeptide Y increases food intake in mice

14 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

The detection and measurement of locomotor deficits in a transgenic mouse model of Huntington's disease are task- and protocol-dependent: influence of non-motor factors on locomotor function

14 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse models

14 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Abnormalities of neurogenesis in the R6/2 mouse model of Huntington's disease are attributable to the in vivo microenvironment.

14 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer's disease

14 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

The putative neuroprotective role of neuropeptide Y in the central nervous system.

14 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice

14 June 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Peptidergic influences on proliferation, migration, and placement of neural progenitors in the adult mouse forebrain

14 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Neuropeptide Y injected in the paraventricular hypothalamus: a powerful stimulant of feeding behavior

14 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.

14 June 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Neuropeptide Y acts at Y1 receptors in the rostral ventral medulla to inhibit neuropathic pain

14 June 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum.

14 June 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Effect of basal forebrain neuropeptide Y administration on sleep and spontaneous behavior in freely moving rats

14 June 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Increased metabolism in the R6/2 mouse model of Huntington's disease.

14 June 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Interaction between neuropeptide Y (NPY) and brain-derived neurotrophic factor in NPY-mediated neuroprotection against excitotoxicity: a role for microglia.

14 June 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

Brain-derived neurotrophic factor in neurodegenerative diseases

14 June 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.EXPNEUROL.2010.07.022

14 June 2024

Identifiers

1 reference

11 November 2017

1 reference